GSA Capital Partners’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-1,413
| Closed | -$386K | – | 1782 |
|
|
2025
Q4 | $386K | Sell |
1,413
-3,363
| -70% | -$914K | 0.03% | 992 |
|
|
2025
Q3 | $1.29M | Buy |
+4,776
| New | +$1.3M | 0.11% | 258 |
|
|
2024
Q4 | – | Sell |
-3,384
| Closed | -$747K | – | 1654 |
|
|
2024
Q3 | $747K | Buy |
3,384
+1,742
| +106% | +$360K | 0.06% | 649 |
|
|
2024
Q2 | $323K | Buy |
+1,642
| New | +$339K | 0.02% | 1230 |
|
|
2023
Q4 | – | Sell |
-1,372
| Closed | -$275K | – | 1546 |
|
|
2023
Q3 | $275K | Sell |
1,372
-17
| -1% | -$3.38K | 0.02% | 1122 |
|
|
2023
Q2 | $257K | Sell |
1,389
-1,513
| -52% | -$280K | 0.03% | 1135 |
|
|
2023
Q1 | $556K | Sell |
2,902
-1,520
| -34% | -$275K | 0.06% | 644 |
|
|
2022
Q4 | $744K | Sell |
4,422
-44
| -1% | -$7.65K | 0.09% | 363 |
|
|
2022
Q3 | $791K | Buy |
4,466
+2,517
| +129% | +$497K | 0.1% | 267 |
|
|
2022
Q2 | $399K | Sell |
1,949
-591
| -23% | -$125K | 0.06% | 637 |
|
|
2022
Q1 | $604K | Buy |
2,540
+1,425
| +128% | +$335K | 0.08% | 418 |
|
|
2021
Q4 | $255K | Buy |
+1,115
| New | +$245K | 0.03% | 1046 |
|
|
2021
Q3 | – | Sell |
-1,147
| Closed | -$244K | – | 1480 |
|
|
2021
Q2 | $244K | Buy |
+1,147
| New | +$242K | 0.03% | 1076 |
|
|
2021
Q1 | – | Sell |
-3,286
| Closed | -$598K | – | 1151 |
|
|
2020
Q4 | $598K | Buy |
3,286
+1,522
| +86% | +$259K | 0.1% | 323 |
|
|
2020
Q3 | $295K | Sell |
1,764
-4,034
| -70% | -$679K | 0.05% | 747 |
|
|
2020
Q2 | $942K | Buy |
+5,798
| New | +$1.04M | 0.53% | 17 |
|
|
2018
Q2 | – | Sell |
-20,149
| Closed | -$3.26M | – | 1706 |
|
|
2018
Q1 | $3.26M | Buy |
+20,149
| New | +$3.21M | 0.17% | 92 |
|
|
2017
Q2 | – | Sell |
-32,795
| Closed | -$3.9M | – | 1706 |
|
|
2017
Q1 | $3.9M | Buy |
+32,795
| New | +$3.94M | 0.21% | 50 |
|
|
2016
Q4 | – | Sell |
-3,008
| Closed | -$314K | – | 1775 |
|
|
2016
Q3 | $314K | Buy |
+3,008
| New | +$314K | 0.02% | 1338 |
|
|
2016
Q1 | – | Sell |
-5,718
| Closed | -$518K | – | 1698 |
|
|
2015
Q4 | $518K | Buy |
5,718
+1,043
| +22% | +$98.2K | 0.03% | 1150 |
|
|
2015
Q3 | $434K | Sell |
4,675
-66,233
| -93% | -$6.3M | 0.02% | 1199 |
|
|
2015
Q2 | $6.6M | Buy |
70,908
+31,350
| +79% | +$2.92M | 0.25% | 31 |
|
|
2015
Q1 | $3.75M | Buy |
+39,558
| New | +$3.66M | 0.15% | 99 |
|
|
2014
Q3 | – | Sell |
-15,886
| Closed | -$1.13M | – | 1731 |
|
|
2014
Q2 | $1.13M | Sell |
15,886
-29,270
| -65% | -$2.06M | 0.05% | 601 |
|
|
2014
Q1 | $3.34M | Sell |
45,156
-52,299
| -54% | -$3.95M | 0.24% | 78 |
|
|
2013
Q4 | $7.65M | Buy |
97,455
+92,372
| +1,817% | +$7.23M | 0.6% | 3 |
|
|
2013
Q3 | $376K | Sell |
5,083
-10,855
| -68% | -$800K | 0.03% | 992 |
|
|
2013
Q2 | $1.21M | Buy |
+15,938
| New | +$1.05M | 0.14% | 167 |
|
Other funds holding CME
VCM
VPM
GSA Capital Partners's CME Position: Q1 2026 in Review
GSA Capital Partners sold out of CME Group (CME) in Q1 2026, closing a stake of 1,413 shares — an estimated $386K sold.
GSA Capital Partners first reported a position in CME in Q2 2013 and held it in 28 quarters. The position peaked at $7.65M in Q4 2013. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.
- GSA Capital Partners reported no remaining CME Group position as of Q1 2026 after selling out during the quarter.
- GSA Capital Partners sold 1,413 CME Group shares in Q1 2026, an estimated $386K.
- GSA Capital Partners first reported a position in CME Group in Q2 2013 and held it in 28 quarters.
- GSA Capital Partners's CME Group position peaked at $7.65M in Q4 2013.
- 1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.
Based on GSA Capital Partners's 13F filing for Q1 2026, filed 8 May 2026.